https://ntp.niehs.nih.gov/go/21025

TDMS Study 96003-06 Pathology Tables

NTP Experiment-Test: 96003-06               INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a)                     Report: PEIRPT02
Study Type: 39 WEEKS                                          ALLYL BROMIDE                                       Date: 03/26/01
Route: GAVAGE                                                                                                     Time: 13:52:06
                                                          FINAL#1/MICE
       Facility:  BIORELIANCE
       Chemical CAS #:  106-95-6
       Lock Date:  10/18/00
       Cage Range:  All
       Reasons For Removal:    All
       Removal Date Range:     All
       Treatment Groups:       Include All
a  Number of animals examined microscopically at site and number of animals with lesion
                                                              Page   1
NTP Experiment-Test: 96003-06               INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a)                     Report: PEIRPT02
Study Type: 39 WEEKS                                          ALLYL BROMIDE                                       Date: 03/26/01  
Route: GAVAGE                                                                                                     Time: 13:52:06  
____________________________________________________________________________________________________________________________________
         C57BL/6 MICE FEMALE                       VEHICLE      8 MG/KG                                                             
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially in Study                          15           15                                                               
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                              2                                                               
    Natural Death                                                   1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                15           12                                                               
  Animals Examined Microscopically                    15           15                                                               
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   Intestine Small, Jejunum                           (15)         (15)                                                             
      Sarcoma                                                       1 (7%)                                                          
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   Tissue NOS                                                      (1)                                                              
      Sarcoma                                                       1 (100%)                                                        
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                             Page   2                                                               
NTP Experiment-Test: 96003-06               INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a)                     Report: PEIRPT02
Study Type: 39 WEEKS                                          ALLYL BROMIDE                                       Date: 03/26/01  
Route: GAVAGE                                                                                                     Time: 13:52:06  
____________________________________________________________________________________________________________________________________
         C57BL/6 MICE FEMALE                       VEHICLE      8 MG/KG                                                             
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   None                                                                                                                             
                                                             Page   3                                                               
NTP Experiment-Test: 96003-06               INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a)                     Report: PEIRPT02
Study Type: 39 WEEKS                                          ALLYL BROMIDE                                       Date: 03/26/01  
Route: GAVAGE                                                                                                     Time: 13:52:06  
____________________________________________________________________________________________________________________________________
         C57BL/6 MICE FEMALE                       VEHICLE      8 MG/KG                                                             
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
TUMOR SUMMARY                                                                                                                       
   Total Animals with Primary Neoplasms (b)                         1                                                               
     Total Primary Neoplasms                                        2                                                               
   Total Animals with Benign Neoplasms                                                                                              
     Total Benign Neoplasms                                                                                                         
   Total Animals with Malignant Neoplasms                           1                                                               
     Total Malignant Neoplasms                                      2                                                               
   Total Animals with Metastatic Neoplasms                                                                                          
     Total Metastatic Neoplasm                                                                                                      
   Total Animals with Malignant Neoplasms                                                                                           
   Uncertain Primary Site                                                                                                           
   Total Animals with Neoplasms Uncertain-                                                                                          
   Benign or Malignant                                                                                                              
     Total Uncertain Neoplasms                                                                                                      
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Primary tumors: all tumors except metastatic tumors                                                                              
                                                             Page   4                                                               
NTP Experiment-Test: 96003-06               INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a)                     Report: PEIRPT02
Study Type: 39 WEEKS                                          ALLYL BROMIDE                                       Date: 03/26/01  
Route: GAVAGE                                                                                                     Time: 13:52:06  
____________________________________________________________________________________________________________________________________
         C57BL/6 MICE MALE                         VEHICLE      8 MG/KG                                                             
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially in Study                          15           15                                                               
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 1                                                                            
  Survivors                                                                                                                         
    Terminal Sacrifice                                14           15                                                               
  Animals Examined Microscopically                    15           15                                                               
____________________________________________________________________________________________________________________________________
 ALIMENTARY SYSTEM                                                                                                                  
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 CARDIOVASCULAR SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 ENDOCRINE SYSTEM                                                                                                                   
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENERAL BODY SYSTEM                                                                                                                
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 GENITAL SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 HEMATOPOIETIC SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                             Page   5                                                               
NTP Experiment-Test: 96003-06               INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a)                     Report: PEIRPT02
Study Type: 39 WEEKS                                          ALLYL BROMIDE                                       Date: 03/26/01  
Route: GAVAGE                                                                                                     Time: 13:52:06  
____________________________________________________________________________________________________________________________________
         C57BL/6 MICE MALE                         VEHICLE      8 MG/KG                                                             
                                                   CONTROL                                                                          
____________________________________________________________________________________________________________________________________
 INTEGUMENTARY SYSTEM                                                                                                               
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 MUSCULOSKELETAL SYSTEM                                                                                                             
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 NERVOUS SYSTEM                                                                                                                     
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 RESPIRATORY SYSTEM                                                                                                                 
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 SPECIAL SENSES SYSTEM                                                                                                              
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
 URINARY SYSTEM                                                                                                                     
   None                                                                                                                             
                                                             Page   6                                                               
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------